Form D · Biotechnology

AutoIVF, Inc.

Natick, MA · CIK 0001807161

Offering snapshot reported Sep 25, 2026 · SEC filing

Reported sold
$1.5M
Offering amount: $1.5M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 7, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 25, 2026Initial$1,500,000No comparison15SEC filing
May 22, 2025Initial$5,000,000No comparison24SEC filing
Jun 14, 2023Initial$2,644,960No comparison15SEC filing
Mar 20, 2020Initial$1,000,000No comparison8SEC filing

Offering details

Securities
Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-598914
Simple Agreement for Future Equity

Source: Form D, filed Sep 25, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Alper Director
Ravi Kapur Director, Executive
Alan Penzias Director
David Sable Director
Dionisios Sakkas Director
Denny Sakkas Director
Mitchell Sayare Director, Executive
Mitchel Sayare Director, Executive
Erin Schardt Director
Mehmet Toner Director
Thomas Toth Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
22 Strathmore Road, Suite 317
Natick, MA, 01760
Phone: 781-363-3530